Virginia Innovation Partnership Corp

NEW YORK, Dec. 14, 2022 /PRNewswire/ -- CIT, a division of First Citizens Bank, today announced that its Healthcare Finance business provided $27.8 million to a joint venture between Kayne Anderson Real Estate and Remedy Medical Properties for the acquisition of a surgical hospital and medical office building portfolio located in Wichita, Kansas. The portfolio includes Kansas Spine & Specialty Hospital and Abay Medical Plaza. Kansas Spine & Specialty Hospital is a regional center for diagnosing and treating disorders of the spine, neck and joints, and is recognized as one of America's 100 best hospitals for spine surgery by Becker's Hospital Review. Abay Medical Plaza is leased to four tenants with the largest tenant being Abay Neuroscience Center – one of the largest neurosurgery practices in Kansas – and the second largest tenant being the Pain Center at Kansas Spine & Specialty Hospital. "Located in Wichita's medical corridor, the surgery center and medical office building within this portfolio are providing essential services to community members who benefit from having a surgical hospital and pain center in the same complex," said Antonio Minchella, senior managing director – Medical Office at Kayne Anderson. "We appreciate working with the knowledgeable and efficient team at CIT Healthcare Finance to arrange financing for our acquisition of this valuable portfolio." "Kayne Anderson Real Estate and Remedy Medical Properties are experienced real estate investors and well-known for their high-quality portfolios of medical office buildings," said William Douglass, managing director and group head for CIT Healthcare Finance. "We are proud to help contribute value to their business plans alongside financing." "With our deep industry relationships, experience and market expertise, we are pleased to advance the goals of Kayne Anderson Real Estate and Remedy Medical Properties by creating unique financing tailored to meet their needs," said Steven Reedy, a managing director in CIT Healthcare Finance. CIT's Healthcare Finance unit provides comprehensive financing and banking solutions to middle market healthcare companies across the U.S. By using a client-focused and industry-centric model, Healthcare Finance can tailor its products and services to help clients meet their needs for capital. About CIT CIT is a division of First Citizens Bank, the largest family-controlled bank in the United States, continuing a unique legacy of strength, stability and long-term thinking that has spanned generations. Parent company, First Citizens BancShares, Inc. (NASDAQ: FCNCA) is a top 20 U.S. financial institution with more than $100 billion in assets. The company's commercial banking segment brings a wide array of best-in-class lending, leasing and banking services to middle-market companies and small businesses from coast to coast. First Citizens also operates a nationwide direct bank and a network of more than 550 branches in 22 states, many in high-growth markets. Industry specialists bring a depth of expertise that helps businesses and individuals meet their specific goals at every stage of their financial journey. Discover more at cit.com/firstcitizens. About Kayne Anderson Real Estate Kayne Anderson Real Estate ("KA Real Estate") is a leading real estate private equity investor in medical office, seniors housing, off-campus student housing, multifamily housing and self-storage. KA Real Estate manages $14.5 billion of real estate AUM (as of 10/31/2022) across opportunistic equity, core equity and real estate debt. KA Real Estate is part of Kayne Anderson Capital Advisors, L.P., a $34 billion alternative investment management firm with more than 38 years of successful experience in the real estate, infrastructure, credit, and growth capital sectors. About Remedy Medical Properties Remedy Medical Properties is a full-service healthcare real estate company and the largest owner of healthcare properties in the country, with more than 28 million square feet and 25 offices spanning 43 states. For healthcare decision-makers who want to maximize the value of their real estate while enhancing their ability to adapt, our national presence enables us to offer the right solutions in the right locations for your organization. Remedy offers unmatched flexibility in every client engagement, and our adaptability enables us to provide more options in ownership, development, leasing, management, and strategy. Our willingness to commit capital, share more risk, and offer greater foresight results in greater resilience, profitability, and peace of mind for our clients. For more information visit . MEDIA RELATIONS: CIT, a division of First Citizens Bank Lexa Tutela 212-461-5305 [email protected] Kayne Anderson Capital Advisors Alexander Candia 561-300-6237 [email protected] SOURCE CIT, a division of First Citizens Bank

NEW YORK, Dec. 1, 2022 /PRNewswire/ -- CIT, a division of First Citizens Bank, today announced that its Healthcare Finance business served as lead arranger of $135.6 million in financing for Superior Biologics Inc. Headquartered in Sharon Hill, Pennsylvania, Superior Biologics is a leading provider of specialty pharmacy and home infusion therapy services to patients contending with a wide variety of chronic illnesses. It currently operates seven accredited pharmacies across the U.S., serving patients in 43 states and having the capability to dispense medications in all 50 states. The financing, which consists of a term loan and a revolving line of credit, will be used to refinance existing debt, fund a shareholder dividend, provide working capital and support growth initiatives. "Our innovative and cost-effective pharmacy and in-home nursing infusion services help lead to optimal therapeutic outcomes and best-in-class patient results," said Ray Mirra, founder and CEO of Superior Biologics. "We appreciated CIT's agility and expertise in arranging financing that supports our business objectives." "We were pleased to again support Superior Biologics with another financing package tailored to advance their business goals," said William Douglass, managing director and group head for CIT's Healthcare Finance business. "We always work closely with Superior Biologics to understand their needs," said David Gibbs, a managing director in Healthcare Finance. "It is a pleasure to work with smart and successful companies and we look forward to continuing our association in the future." CIT's Healthcare Finance unit provides comprehensive financing and banking solutions to middle market healthcare companies across the U.S. By using a client-focused and industry-centric model, Healthcare Finance can tailor its products and services to help clients meet their needs for capital. About CIT CIT is a division of First Citizens Bank, the largest family-controlled bank in the United States, continuing a unique legacy of strength, stability and long-term thinking that has spanned generations. Parent company, First Citizens BancShares, Inc. (NASDAQ: FCNCA) is a top 20 U.S. financial institution with more than $100 billion in assets. The company's commercial banking segment brings a wide array of best-in-class lending, leasing and banking services to middle-market companies and small businesses from coast to coast. First Citizens also operates a nationwide direct bank and a network of more than 550 branches in 22 states, many in high-growth markets. Industry specialists bring a depth of expertise that helps businesses and individuals meet their specific goals at every stage of their financial journey. Discover more at cit.com/firstcitizens. MEDIA RELATIONS: John M. Moran 212-461-5507 [email protected] SOURCE CIT, a division of First Citizens Bank

New study shows a man’s overall health, in combination with taking nutritional supplements, is associated with enhanced sperm capacitation ability, as measured by Cap-Score, and an increase in male fertility.Improving a man’s overall health, in combination with nutritional supplementation, had little to no impact on semen analysis measures, which are independent of Cap-Score and fail to identify over 50% of infertility cases. MOUNTAINSIDE, N.J., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Androvia LifeSciences -- In a study being presented today at the American Society for Reproductive Medicine (ASRM; Anaheim, CA; Oct 22-26, 2022), two independent clinicians, Dr. Fady Sharara (Virginia Center for Reproductive Medicine) and Dr. Eric Seaman (New Jersey Urology, A Summit Health Company), reported that lifestyle changes and nutritional supplements improve the Cap-Score and male fertility. Dr. Sharara’s and Dr. Seaman’s study included 55 patients. The results suggest that changes in lifestyle and nutritional supplements led to an improvement in the Cap-Score in 67% (37/55) participants. In addition, little change was seen in the traditional semen analysis measurements. Importantly, those men with lower Cap-Scores showed the most improvement. Overall, the lifestyle changes and nutritional supplementation resulted in a 25% increase in a man’s probability of generating a pregnancy. Thus, if a man knows that he has a low Cap-Score, he can improve his lifestyle and take nutritional supplements, allowing him to become an invested partner in the couple’s pathway to pregnancy. Evidence suggest that traditional semen analysis parameters have been declining for more than 50 years. Although the causative factors have yet to be fully explained, potential reasons include lack of exercise, poor diet, and exposure to toxins such as through pesticides in food, alcohol use and smoking. Although traditional semen analysis is the cornerstone of a fertility examination for a man, it is generally recognized that semen analysis is not a reliable test of a man’s fertility. Therefore, Drs. Sharara and Seaman tested whether changes in lifestyle, including taking nutritional supplements, and improving diet, exercise, and sleep, while reducing smoking, alcohol use and other behaviors, would influence a man’s actual fertility as measured by the Cap-Score. To fertilize, sperm must first mature through a process known as “capacitation”. Sperm that don’t capacitate cannot fertilize an egg. Androvia LifeSciences (Mountainside, NJ) has developed the Cap-Score, a diagnostic test that measures the percentage of a man’s sperm that can capacitate. Several prior studies have prospectively shown that the Cap-Score can accurately predict a man’s fertility. Androvia LifeSciences is a privately held company focused on developing new male fertility diagnostics for patients and clinicians. The Cap-Score test assists in accurately identifying the role that male infertility plays in a couple's journey toward pregnancy. With this information, Androvia hopes to help guide personalized fertility treatment options to increase success, reduce costs, and shortening the pathway to parenthood. Androvia LifeScience’s laboratory is CLIA compliant, New Jersey DOH approved, accredited by the College of American Pathology, and licensed by New York State, as both a facility and as an approved Laboratory Test. The Cap-Score Test is available as a Home Collection Kit and is currently available to individuals throughout the United States. Please visit www.capscoretest.com to learn more. SOURCE Androvia LifeSciences Contact Information Androvia LifeSciences info@androvialife.com